Lamotrigin Mylan

Lamotrigine, the active ingredient in Lamotrigin Mylan, is an anticonvulsant presented as an oral dosage form for oral use. It is employed to treat various seizure types and to stabilise mood in bipolar disorder, providing therapeutic benefit for patients requiring long‑term seizure control or mood management.

GNH USA supplies Lamotrigin Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant and mood‑stabilising agent used in several neurological and psychiatric conditions.

- Epilepsy: reduces the frequency of focal and generalized seizures. - Bipolar disorder: maintains mood stability and helps prevent manic and depressive episodes. - Lennox‑Gastaut syndrome: decreases the number of drop attacks in this severe childhood epilepsy.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate pain often improving with rest. - Nausea: occasional upset stomach or vomiting. - Rash: mild skin redness or itching. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin blistering requiring urgent medical care. - Toxic epidermal necrolysis: extensive skin detachment, a medical emergency. - Blood dyscrasias: rare cases of agranulocytosis or aplastic anemia. - Hepatic failure: severe liver injury presenting with jaundice. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe hypersensitivity: anaphylaxis or angioedema.

When prescribing Lamotrigine, clinicians should consider several safety measures.

- Skin monitoring: watch for rash or signs of severe skin reactions. - Dose adjustment: modify dose when used with enzyme‑inducing or inhibiting drugs. - Discontinuation: avoid abrupt stopping to prevent seizure recurrence. - Hepatic function: use caution in patients with liver impairment. - Pregnancy counseling: discuss potential risks and benefits with women of child‑bearing potential. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially diminishing efficacy. - Phenytoin: lowers lamotrigine exposure, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating monitoring. - Serotonergic agents: combined use can increase the risk of serotonin syndrome. - Phenobarbital: accelerates lamotrigine metabolism, possibly requiring dose increase.